TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Slide background
Slide background
  • April 14, 2020

NAAS, Ireland—Kerry acquired Pevesa Biotech, Seville, Spain, a provider of non-allergenic, non-GMO plant proteins for the infant-, general-, and clinical-nutrition markets. The acquisition strengthens Kerry’s capabilities in the hydrolyzed plant protein space for specialized nutrition and expands the company’s capacity to serve the rapidly growing, high-quality, organic plant protein market.